Combination of bevacizumab and lomustine with first recurrence of glioblastoma prolongs progression-free survival, but not overall survival

European Organisation for Research and Treatment of Cancer. "Combination of bevacizumab and lomustine with first recurrence of glioblastoma prolongs progression-free survival, but not overall survival." ScienceDaily. ScienceDaily, 23 November 2015. <http://ift.tt/1R1ho2t;.

European Organisation for Research and Treatment of Cancer. (2015, November 23). Combination of bevacizumab and lomustine with first recurrence of glioblastoma prolongs progression-free survival, but not overall survival. ScienceDaily. Retrieved November 23, 2015 from http://ift.tt/1jgk9iN

European Organisation for Research and Treatment of Cancer. "Combination of bevacizumab and lomustine with first recurrence of glioblastoma prolongs progression-free survival, but not overall survival." ScienceDaily. http://ift.tt/1jgk9iN (accessed November 23, 2015).

Share on Google Plus

About Unknown

My blog is the place to update the latest information on sports, science and technology ... If you found this article good, useful please the share for others to see, even if you want to design a ecommerce website or web edit or set a special plugin functionality, please contact us now (Information in the footer)